
zzso zzso zzso has a poor zzso zzso zzso of patients are not candidates for zzso treatments at the time of zzso hence zzso zzso zzso zzso zzso zzso zzso systemic zzso are zzso zzso zzso have disappointing zzso The increasing knowledge in the molecular biology of zzso will increase the possibilities of targeted zzso The zzso zzso inhibitor zzso is the only drug which has zzso The zzso zzso zzso zzso agents zzso as well as the zzso of zzso zzso are zzso Combination of zzso or other zzso agents with local zzso procedure zzso zzso zzso zzso zzso or with zzso zzso also can be zzso zzso of zzso pathway, zzso compounds, zzso of the cell cycle as well as the zzso and zzso therapy can be other potential promising targets in zzso 

